Gene Expression Regulation, Neoplastic
"Gene Expression Regulation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.
| Descriptor ID |
D015972
|
| MeSH Number(s) |
G05.308.370
|
| Concept/Terms |
Gene Expression Regulation, Neoplastic- Gene Expression Regulation, Neoplastic
- Regulation of Gene Expression, Neoplastic
- Regulation, Gene Expression, Neoplastic
- Neoplastic Gene Expression Regulation
|
Below are MeSH descriptors whose meaning is more general than "Gene Expression Regulation, Neoplastic".
Below are MeSH descriptors whose meaning is more specific than "Gene Expression Regulation, Neoplastic".
This graph shows the total number of publications written about "Gene Expression Regulation, Neoplastic" by people in this website by year, and whether "Gene Expression Regulation, Neoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 2 | 1 | 3 |
| 1998 | 3 | 1 | 4 |
| 1999 | 0 | 2 | 2 |
| 2001 | 2 | 0 | 2 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 1 | 3 |
| 2004 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 3 | 4 |
| 2014 | 0 | 4 | 4 |
| 2015 | 2 | 1 | 3 |
| 2016 | 0 | 6 | 6 |
| 2017 | 2 | 2 | 4 |
| 2018 | 2 | 5 | 7 |
| 2019 | 1 | 2 | 3 |
| 2020 | 2 | 4 | 6 |
| 2021 | 1 | 3 | 4 |
| 2022 | 0 | 1 | 1 |
| 2024 | 2 | 3 | 5 |
| 2025 | 2 | 3 | 5 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Expression Regulation, Neoplastic" by people in Profiles.
-
In vivo inhibition of TDO2 in fibroids results in widespread alteration in the tumor transcriptome. Clin Sci (Lond). 2026 Jun 10; 140(6):1099-1117.
-
Arctigenin Suppresses Breast Cancer Growth In Vitro and In Vivo Through Subtype-Specific Multi-Targeting Activity. Int J Mol Sci. 2026 Jun 03; 27(11).
-
c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT. Mol Cancer. 2025 Dec 15; 25(1):16.
-
HDAC4/MybL1/YAP novel signaling axis is required for pancreatic cancer metastasis to the liver. Int J Biol Sci. 2025; 21(15):6907-6925.
-
The Roles of Non-Coding RNAs in the Pathogenesis of Uterine Fibroids. Cells. 2025 Aug 20; 14(16).
-
Comparative Analysis of Differentially Expressed Long Non-Coding RNA in Pre- and Postmenopausal Fibroids. Int J Mol Sci. 2025 Jul 16; 26(14).
-
Differential Expression of Small Non-Coding RNAs in Uterine Leiomyomas. Int J Mol Sci. 2025 Feb 16; 26(4).
-
Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells. Drug Resist Updat. 2025 Mar; 79:101196.
-
The in?vivo effects of knockdown of long non-coding RNA XIST on fibroid growth and gene expression. FASEB J. 2024 Nov 15; 38(21):e70140.
-
The Functional Role of the Long Non-Coding RNA LINCMD1 in Leiomyoma Pathogenesis. Int J Mol Sci. 2024 Oct 27; 25(21).